Literature DB >> 29579186

Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE.

Antonio Hernández-Madrid1, Thomas Paul2, Dominic Abrams3, Peter F Aziz4, Nico A Blom5,6, Jian Chen7, Massimo Chessa8, Nicolas Combes9, Nikolaos Dagres10, Gerhard Diller11, Sabine Ernst12, Alessandro Giamberti13, Joachim Hebe14, Jan Janousek15, Thomas Kriebel16, Jose Moltedo17, Javier Moreno1, Rafael Peinado18, Laurent Pison19, Eric Rosenthal20, Jonathan R Skinner21, Katja Zeppenfeld22.   

Abstract

The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.

Entities:  

Mesh:

Year:  2018        PMID: 29579186     DOI: 10.1093/europace/eux380

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  38 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

Review 2.  Current spectrum, challenges and new developments in the surgical care of adults with congenital heart disease.

Authors:  Jürgen Hörer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 3.  Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia.

Authors:  Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 4.  Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review.

Authors:  Kristina Wasmer; Lars Eckardt; Helmut Baumgartner; Julia Köbe
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 5.  Heart failure in adults with congenital heart disease: a narrative review.

Authors:  Elvin Zengin; Christoph Sinning; Christopher Blaum; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch; Paulus Kirchhof; Nigel E Drury; Victoria M Stoll
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 6.  Pregnancy in adults with congenital heart disease.

Authors:  Elvin Zengin; Götz Mueller; Stefan Blankenberg; Yskert von Kodolitsch; Carsten Rickers; Christoph Sinning
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

7.  Risk factors of postoperative acute kidney injury in patients with complex congenital heart disease and significance of early detection of serum transcription factor Nkx2.5.

Authors:  Haiyu Chen; Qiuqing Ke; Guoxing Weng; Jiayin Bao; Jie Huang; Licheng Yan; Fuzhen Zheng
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

9.  Advanced mapping strategies for ablation therapy in adults with congenital heart disease.

Authors:  Fares-Alexander Alken; Niklas Klatt; Paula Muenkler; Katharina Scherschel; Christiane Jungen; Ruken Oezge Akbulak; Ann-Kathrin Kahle; Melanie Gunawardene; Mario Jularic; Leon Dinshaw; Jens Hartmann; Christian Eickholt; Stephan Willems; Fridrike Stute; Goetz Mueller; Stefan Blankenberg; Carsten Rickers; Christoph Sinning; Elvin Zengin-Sahm; Christian Meyer
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 10.  Atrial septal defects and pulmonary arterial hypertension.

Authors:  Heba Nashat; Claudia Montanaro; Wei Li; Aleksander Kempny; Stephen J Wort; Konstantinos Dimopoulos; Michael A Gatzoulis; Sonya V Babu-Narayan
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.